BRESCIA, Italy, June 23, 2025 (GLOBE NEWSWIRE) -- After 5 racing days , 1900 kilometres and over 400 classic cars in movement, today the forty-third re-enactment of the 1000 Miglia ended in Brescia . A special edition, bringing back to ...
Read MoreIn an uncertain world in which it seems uncertainty is forever knocking at the front door, never has our health been more important to safeguard. Contemporary way of living, high medical expenses and unexpected ailments have ensured that ...
Read MorePR Newswire SAN FRANCISCO, June 24, 2025 Achieved statistical significance on primary endpoint at week 16 for mean percent change in EASI score from baseline for all rezpegaldesleukin arms versus placebo Achieved statistical significance ...
Read MorePR Newswire GRAND RAPIDS, Mich., June 24, 2025 Families learn life-saving techniques while raising funds for children with special heart needs GRAND RAPIDS, Mich., June 24, 2025 /PRNewswire/ -- Students at 25 National Heritage Academies ...
Read MorePR Newswire NEW DELHI, June 24, 2025 Colgate's Oral Health Movement reveals India's Oral Health Score as 2.6 out of 5, signalling the need for prioritization of Oral Care in the country NEW DELHI, June 24, 2025 /PRNewswire/ -- ...
Read MorePR Newswire NEW YORK, June 24, 2025 – At Week 144, 92.3% of Patients Remained Free of 12-Week Confirmed Disability Worsening (CDW) With 92.7% Remaining Free of 24-Week CDW – – Vidofludimus Calcium Continues to Demonstrate Favorable ...
Read MorePR Newswire CAMBRIDGE, Mass., June 24, 2025 CAMBRIDGE, Mass., June 24, 2025 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven ...
Read MorePR Newswire DOYLESTOWN, Pa., June 24, 2025 DOYLESTOWN, Pa., June 24, 2025 /PRNewswire/ -- Sterotherapeutics LLC, a clinical-stage biopharmaceutical company focused on rare endocrine diseases, today announced that the first patient has been ...
Read MorePR Newswire COPENHAGEN, Denmark, June 24, 2025 COPENHAGEN, Denmark, June 24, 2025 /PRNewswire/ -- Breye Therapeutics ApS (Breye), a clinical-stage ophthalmology focused biopharmaceutical company developing oral therapeutics for the early ...
Read MorePR Newswire VALBY, Denmark, June 24, 2025 VALBY, Denmark, June 24, 2025 /PRNewswire/ -- Lundbeck today announces that orphan drug designation has been granted to Lu AG13909 by the US Food and Drug Administration (FDA) on 12 May 2025 and the ...
Read MorePR Newswire VIENNA and ZELL AM SEE, Austria, June 24, 2025 "Anyone visiting somebody in a hospital must disinfect their hands," says the long-standing advisor to the World Health Organization – Pittet to visit Austria on June 26, 2025 ...
Read MorePR Newswire SUZHOU, China, June 23, 2025 SUZHOU, China, June 23, 2025 /PRNewswire/ -- BrightGene Pharmaceutical Co., Ltd., an international, innovation-driven pharmaceutical company, presented data from two Phase 2 studies for BGM0504, its ...
Read MorePR Newswire CHICAGO, June 23, 2025 Study Results Signal Paradigm Shift in Diabetes Care for Patients with Difficult-to-Control Type 2 Diabetes CHICAGO, June 23, 2025 /PRNewswire/ -- New findings from the CATALYST study show that the use ...
Read MorePR Newswire LEXINGTON, Ky., June 23, 2025 Digital tool equips healthcare providers with trusted visual content to simplify complex heart information at the point of care LEXINGTON, Ky., June 23, 2025 /PRNewswire/ -- Medmovie, Inc., a ...
Read MorePR Newswire FARMINGTON HILLS, Mich., June 23, 2025 FARMINGTON HILLS, Mich., June 23, 2025 /PRNewswire/ -- The International Hearing Society (IHS) kicked off its "Help Hearing" campaign while serving as one of 171 exhibitors at the Health ...
Read MorePR Newswire SOMERSET, N.J., June 23, 2025 SOMERSET, N.J., June 23, 2025 /PRNewswire/ -- ProCure Proton Therapy Center reminds area residents about the critical importance to men of prostate-specific antigen (PSA) screenings for prostate ...
Read MorePR Newswire SAN JOSE, Calif., June 23, 2025 Fourth cohort dose is three million CAR positive cells; thirty times higher than the first cohort dose SAN JOSE, Calif., June 23, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the ...
Read MorePR Newswire WARREN, N.J., June 23, 2025 – Broad label inclusive of all ages and disease severities – – Launch to be initiated in Germany – WARREN, N.J., June 23, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today ...
Read MorePR Newswire CAMBRIDGE, Mass., June 23, 2025 Updated data from DeFianCe study continue to demonstrate statistically significant improvements in PFS among the DKK1-high, VEGF-naïve and liver metastasis subgroups Board of Directors has ...
Read MorePR Newswire LOMA LINDA, Calif., June 23, 2025 Researchers found that a vegetarian diet was associated with even greater risk reduction of stomach cancer, as high as 45%, as well as lymphomas by 25%. This is the first study with strong ...
Read MorePR Newswire KANAZAWA, Japan, June 23, 2025 KANAZAWA, Japan, June 23, 2025 /PRNewswire/ -- Researchers at the Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, report in Small, a weekly peer-reviewed scientific journal covering ...
Read MorePR Newswire JINAN, China, June 23, 2025 JINAN, China, June 23, 2025 /PRNewswire/ -- On May 29, 2025, Professor Sun Jinpeng's team and Professor Yu Xiao's team at Shandong University, collaborating with Professor Jiang Changtao from Peking ...
Read MorePR Newswire SHANGHAI and NANJING, China and SAN FRANCISCO, June 22, 2025 SHANGHAI and NANJING, China and SAN FRANCISCO, June 22, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, ...
Read MorePR Newswire HELSINKI, June 23, 2025 HELSINKI, June 23, 2025 /PRNewswire/ -- New research presented today at the European Academy of Neurology (EAN) Congress 2025 reveals that frequent nightmares are associated with significantly accelerated ...
Read MorePR Newswire CHICAGO, June 22, 2025 Oral formulation demonstrates comparable cardiovascular benefits to injectable GLP-1s CHICAGO, June 22, 2025 /PRNewswire/ -- A recent study found that oral semaglutide offers meaningful cardiovascular ...
Read MorePR Newswire PLAINSBORO, N.J., June 22, 2025 PLAINSBORO, N.J., June 22, 2025 /PRNewswire/ -- Novo Nordisk today presented results from the phase 3b FRONTIER5 trial showing that a direct switch to investigational Mim8 (denecimig) prophylaxis ...
Read MorePR Newswire MATSUMOTO, Japan, June 22, 2025 In a landmark advancement for women's cancer research, Dr. Takuma Hayashi and his team have made groundbreaking discoveries that could transform our understanding and treatment of uterine ...
Read MorePR Newswire CHICAGO, June 22, 2025 Once-weekly insulin helped patients achieve an average A1C of 6.92% in QWINT-1 trial Results support once-weekly insulin as effective alternative to daily treatment CHICAGO, June 22, 2025 ...
Read MorePR Newswire CHICAGO, June 22, 2025 Findings Highlight Potential for Novel Approach to Insulin Delivery in Pediatric Population CHICAGO, June 22, 2025 /PRNewswire/ -- Today, a new study demonstrates inhaled insulin as a safe and effective ...
Read MorePR Newswire CHICAGO, June 22, 2025 Once-weekly medication results in weight loss of up to 22.7% in adults without diabetes and 15.7% in those with type 2 diabetes CHICAGO, June 22, 2025 /PRNewswire/ -- Findings from two studies ...
Read MorePR Newswire CHICAGO, June 21, 2025 This challenge Kickstarts additional investments through the new ADA Innovation Fund CHICAGO, June 21, 2025 /PRNewswire/ -- As the American Diabetes Association® (ADA) celebrates its 85th anniversary, ...
Read MorePR Newswire CHICAGO, June 21, 2025 Common obesity drug reduced the risk of disease progression by 54% CHICAGO, June 21, 2025 /PRNewswire/ -- Today, a new analysis demonstrates the vascular benefits of semaglutide in patients with ...
Read MoreSubscribe to our Free Newsletters!